Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
International Journal of Cardiology. Heart & Vessels|February 17, 2018
Seven-year follow-up of percutaneous closure of patent foramen ovaleNaqibullah Mirzada, Per Ladenvall, Per-Olof Hansson, et al.Stroke|September 24, 2005
Fibrinolytic gene polymorphism and ischemic strokeKatarina Jood, Per Ladenvall, Anna Tjärnlund-Wolf, et al.Thrombosis and Haemostasis|February 19, 2002
Tissue-type plasminogen activator -7,351C/T enhancer polymorphism is associated with a first myocardial infarctionPer Ladenvall, Lars Johansson, Jan-Håkan Jansson, et al.Neurology|July 13, 2019
Disability after minor stroke and TIA: A secondary analysis of the SOCRATES trialBrett Cucchiara, Donna Kurowski George, Scott E Kasner, et al.Journal of Hypertension|October 10, 2020
Long-term risk of stroke and myocardial infarction in middle-aged men with a hypertensive response to exercise: a 44-year follow-up studyKok W Giang, Per-Olof Hansson, Zackarias Mandalenakis, et al.International Journal of Stroke : Official Journal of the International Stroke Society|February 13, 2019
The Acute S<u>t</u>roke or Transient Isc<u>h</u>emic Attack Treated with Tic<u>a</u>gre<u>l</u>or and Aspirin for Pr<u>e</u>vention of <u>S</u>troke and Death (THALES) trial: Rationale and designS Claiborne Johnston, Pierre Amarenco, Hans Denison, et al.JAMA Neurology|November 7, 2020
Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical TrialPierre Amarenco, Hans Denison, Scott R Evans, et al.The New England Journal of Medicine|July 16, 2020
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIAS Claiborne Johnston, Pierre Amarenco, Hans Denison, et al.Stroke|November 17, 2020
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic OriginPierre Amarenco, Hans Denison, Scott R Evans, et al.Stroke (Hoboken, N.J.)|January 26, 2026
Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA-4: Time and Severity Matter MostMauricio Concha, Lizhen Xu, MacKenzie Horn, et al.Pageof 4